SBI Securities Co., Ltd.

SEC CIK: 0001851815
Latest filing: Jul 22, 2026

SEC filings (opens in a new tab)

INZY holding history

Inozyme Pharma, Inc. in every 13F filed by SBI Securities Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

INZY overview All 13F holders of INZY Full Q2 2026 holdings

Shares (Q3 2025): 0; Sold out in Q3 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q4 2024

Holdings of INZY by SBI Securities Co., Ltd., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2025	0	$0	0.0%	−34−100.0%	Sold out	Holders
Q2 2025	34	$136	<0.1%	00.0%	Unchanged	Holders
Q1 2025	34	$31	<0.1%	00.0%	Unchanged	Holders
Q4 2024	34	$94	<0.1%	–	No prior filing	Holders